May 13 - 14, 2024
National Institutes of Health
9000 Rockville Pike
Bethesda, Maryland 20892
Natcher Conference Center, Bldg 45
Ruth L. Kirschstein Auditorium

Building on the foundation of cell-free DNA prenatal testing, the field of liquid biopsy research has rapidly evolved, with uses spanning from early detection of cancer and monitoring of organ transplants. Unlike traditional biopsy methods that require invasive procedures to obtain tissue samples, liquid biopsies use simpler methods to detect disease markers, including cells themselves, in different biofluids, including blood, urine, and even cerebral spinal fluid. This less invasive approach allows for repeated monitoring over time.

Attending the conference will be an excellent opportunity to stay up-to-date on the latest developments and advancements in the field of liquid biopsies. Researchers and professionals from all over the world will be sharing their insights and results, and you'll have the chance to network with others in the field, providing valuable opportunities for collaboration, learning, and professional growth. Young investigators and trainees are especially encouraged to attend career roundtable discussions over lunch, and all attendees are invited to submit abstracts for poster sessions on both days of the conference as well as for consideration for short oral presentations. In keeping with NIH's mission to provide equitable and inclusive conference experiences, attendance is free -- there will be no registration fee for any attendees. This conference is open to members of the NIH community, academic researchers outside of the NIH, and members of pharma/industry.

The New Frontiers in Liquid Biopsies: Data, Technology and Translational Potential conference is sponsored by the Center for Cancer Research, NCI and the National Heart Lung and Blood Institute, NIH.

Deadline to register will be Monday, May 6, 2024
Deadline to submit an abstract will be Monday, February 12, 2024

Registration and abstract submission forms will be available soon. To receive updates on this conference, including when registration and abstract submission open, please join the NIH Liquid Biopsies SIG email list by sending an email to Anna Baj at anna.baj@nih.gov